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Abstract
Background:Asthma attacks are common and have significant physical, psychological,
and financial consequences. Improving the assessment of a child's risk of subsequent
asthma attacks could support front-line clinicians’ decisions on augmenting chronic
treatment or specialist referral. We aimed to identify predictors for emergency
department (ED) or hospital readmission for asthma from the published literature.
Methods:We searched MEDLINE, EMBASE, AMED, PsycINFO, and CINAHL with no
language, location, or time restrictions. We retrieved observational studies and
randomized controlled trials (RCT) assessing factors (personal and family history, and
biomarkers) associated with the risk of ED re-attendance or hospital readmission for
acute childhood asthma.
Results: Three RCTs and 33 observational studies were included, 31 from Anglophone
countriesandnonefromAsiaorAfrica.Therewasanunclearorhigh riskofbias in14of the
studies, including 2 of the RCTs. Previous history of emergency or hospital admissions for
asthma,youngerage,African-Americanethnicity, and lowsocioeconomic status increased
risk of subsequent ED and hospital readmissions for acute asthma. Female sex and
concomitant allergic diseases also predicted hospital readmission.
Conclusion: Despite the global importance of this issue, there are relatively few high
quality studies or studies from outside North America. Factors other than symptoms
are associated with the risk of emergency re-attendance for acute asthma among
children. Further research is required to better quantify the risk of future attacks and to
assess the role of commonly used biomarkers.
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1 | INTRODUCTION
Asthma is the most frequent chronic disease in children1 and its
worldwide prevalence is still rising, with an estimated 300 million
people affected.2 For many years, daily symptoms have been the focus
of treatment guidelines, and physicians have used control question-
naires to guide treatment adjustments. However, current guidelines3,4
have an increasing focus on the risk of adverse outcomes, such as
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
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asthma attacks, as this risk is not directly correlated with daily control.
Children with largely well-controlled symptoms are still at risk of
developing severe asthma attacks.5
Asthma attacks are common6 and are associated with high
healthcare costs7 as well as missed school and workdays. They cause
anxiety8 and carry a risk of death and long-term effects such as loss of
lung function.9 These acute events are especially relevant for children
among whom there is the greatest potential for loss of lung function.
Attacks often follow a viral respiratory tract infection10,11 but
secondary care attendance is generally preventable. Attacks may
occur despite the use of inhaled corticosteroids,5,12 though it is neither
affordable nor safe to provide all children with more aggressive
treatment, particularly in low-middle income countries. It is therefore
important to be able to identify patients at greatest risk of further
attacks and hospital admission to better prioritize limited resources
and provide additional education and support or adjustments to
treatment where most needed.
Currently, it is not possible to predict which children among those
treated for an acute asthma attack, are at a greater risk of suffering
repeated attacks. Physicians treating asthmatic patients are identifying
rather poorly who is at risk of asthma attacks.13 The development of a
tool to enable clinicians to identify such children could be useful to
optimize treatment strategies and address modifiable risk factors. This
is especially relevant when treating patients with discordant manifes-
tations of asthma such as few daily symptoms but evidence from
biomarkers of active eosinophilic inflammation in the airways and
therefore a high risk of exacerbations, and vice versa,14 and when
healthcare resources are stretched. Individualizing therapy has the
potential to reduce the patient's risk of adverse outcomes from their
disease and from medications.
Several factors have been associated with a higher risk of attack
among asthmatic children,15 both aspects of clinical history such as
past attacks and objective measures such as low FEV1. However,
findings from large database or cohort studies do not necessarily
reflect the population seen in the emergency department (ED) or
hospital ward. They therefore may not be informative for the common
clinical scenario of reviewing a child in the ED or ward and deciding
who needs changes in treatment or specialist referral. We therefore
set out to identify predictors (personal and family history, and
biomarkers) for subsequent asthma attacks in children attending
hospital with an acute episode from the published literature. The aimof
the study was to collate information that could support targeted
secondary prevention interventions.
2 | MATERIALS AND METHODS
2.1 | Data sources and search strategy
We conducted systematic searches of bibliographic databases as
described in the Supporting Information (E-Table S1). All databases
were searched from their inception to the present with no language of
publication restriction. Searches were carried out by a Cochrane
Information Specialist up to 9th January 2017. Duplicate references
were removed using reference management software (EndNote X7).
The reference list of each selected publication was hand-searched for
relevant studies.
2.2 | Study selection
Studies with the following criteria were included: (1) cohort and
case-cohort observational design analyzing factors related to asthma
clinical history, previous treatment, lung function, biomarkers, or
readily measured environmental exposures; or controlled trials that
involve a lifestyle or social (not educational or pharmaceutical)
interventions; (2) asthmatic children aged between 5 and 15 years
old (among the age range of the study) recruited from the ED or ward,
treated for an acute asthma exacerbation, included as participants; (3)
emergency re-attendance or hospital readmission due to an asthma
attack listed as outcomes.
The list of abstract and titles was reviewed to exclude publications
that were clearly not contributory on this basis and duplicate titles. Full
text articles of selected paperswere obtained via University library and
inter-library loan and reviewed for eligibility, excluding those not
fulfilling inclusion criteria.
2.3 | Data extraction
Data were extracted by three independent authors using a standard
data extraction form. Possible disagreements were resolved by
discussion. RevMan 5 and Endnote X7 software were used to assist
in the collection and management of data from abstracts and papers.
2.4 | Quality and risk of bias assessment
Studies’ accuracy and risk of bias was assessed using the criteria of the
Cochrane Handbook for Systematic Reviews of Interventions by three
independent authors. Observational studies’ quality was also assessed
using the Newcastle-Ottawa Quality Assessment Scale,16 with a score
of seven or more defined as of high methodological quality.
2.5 | Analysis
Data from comparable studies were combined in quantitative analyses.
We pooled data using a random effect model in RevMan5, creating
pooled estimates of effects for Hazard and Odds Ratios separately.
Reports that presented the results using mean values, with no other
data, were not included in the meta-analyses. We used the generic
inverse variance as the analysismethod for someof the pooled estimate
of effects, as some studies only reported Odds or Hazard Ratios.
We represented an estimate of the degree of variation between
study outcomes using the I2 statistic.17 Overall pooled estimates of
effect are presented on the basis of being informative to some degree
if I2 was high, if either there were few studies (a situation where I2 can
be imprecise or biased), or if the studies found a consistent direction of
effect whichwould imply that factor wasworth consideration in future
prospective studies.
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3 | RESULTS
A total of 3259 recordswere identified and screened for eligibility with
one additional paper obtained through reference list screening
(Figure 1). Forty-three papers fulfilled our inclusion criteria after
full-text screening, accounting for 36 studies.
3.1 | Studies’ characteristics and definitions
3.1.1 | Design, participants, and setting
Twenty-three studies were retrospective analyses of health-care
databases. There were six prospective cohorts, three randomized-
controlled trials (RCT), and four with other prospective designs. Most
studies were carried out in North America (21 in USA and 3 in Canada).
Participants were recruited among inpatients admitted for acute
asthma in most of the studies (27) (Table 1).
3.1.2 | Outcome
The study outcome was ED re-attendance in 4 reports, ED or hospital
readmission in 6, hospital readmission alone in 21 studies and a further
5 studies analyzed data for both outcomes separately.
3.1.3 | Predictors
The risk factors or predictors studied varied amongst studies,
including: socio-demographic characteristics such as age, gender,
sex, and socioeconomic status (SES, including household/neighbor-
hood income, private vs public insurance and working rank); and
asthma characteristics (severity, treatment, previous admissions).
3.2 | Risk of bias
The number of reports with low, unclear, or high risk of bias was
22, 7, and 7, respectively. Those with an unclear risk of bias lacked
information on relevant aspects of the methods, mainly sample
selection, or did not state clearly the number or factors studied in order
to assess reporting bias. The details of the risk of bias assessments are
shown in E-Table S2.
3.3 | Predictors
3.3.1 | Factors related to the person
Age
The effect of age on the future risk of ED or hospital readmission was
examined in 16 studies (E-Table S3). There was a marked variation in
the age group classification and statistical methods used for the
comparisons, precluding a meta-analysis of this factor. Studies were
consistent in reporting that younger children had a higher risk of ED or
hospital readmission.
Sex
Six reports analyzed sex as a risk factor for ED and 17 for hospital
readmission, though some of them stratified its effect by age. There
was a decreased odds of hospital readmission among boys compared
to girls (OR 0.91, 95%CI: 0.86-0.97; N = 67706; I2 = 52%) in the
pooled analysis of data from 17 studies (Figure 2C), but no difference
in the pooled analysis of other two studies reporting hazard
ratios (Figure 2D). There was no difference in ED re-attendance by
sex in the studies reporting either odds or hazard ratios (Figures 2A
and 2B).
Ethnicity
The effect of ethnicity on ED or hospital readmission was included in
18 reports, using different classifications. The most frequent was the
comparison between black or African-American and white or other
origins, and the risk of readmission for asthma. There was an increased
rate of ED re-attendance among African-American compared to white
FIGURE 1 Flow diagram of included and excluded studies
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children (HR: 1.60, 95%CI: 1.29–1.98; N = 12457; I2: 52%) in the
pooled analysis of three studies reporting Hazard Ratios (Figure 3A).
The results of seven studies analyzing the association between
black ethnicity and the odds of hospital readmission for acute
asthma are shown in Figure 3B. The pooled result is not shown given
the marked heterogeneity in study results (I2 = 95%). Four other
studies reporting Hazard Ratios for hospital readmission showed no
association between black ethnicity and hospital readmission rate
(Figure 3C), but again were apparently heterogeneous in their
findings (I2 = 81%). One paper studying hospital readmission was
excluded from the meta-analysis as results were stratified by age and
sex.19
Socioeconomic status (SES)
Twenty-one reports examined SES as a predictor for ED or hospital
readmission for asthma. The specific predictor used differed, with
FIGURE 2 Forest plots for the association of sex with emergency department re-attendance and hospital readmission for acute asthma in
children using a random effects model. (Figure 2A-2D showing separate estimations for odds and hazard ratios)
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public insurance (vs private or other) or low household income being
the most frequent markers adopted for low SES. A meta-analysis
of data from four studies showed increased odds of ED re-attendance
for acute asthma in children of low SES (OR: 1.23; 1.17-1.30;
N = 31466) (Figure 4A), consistent with the pooled analysis of
other three studies reporting HR (HR: 1.40, 95%CI: 1.08-1.82;
N = 41,247) (Figure 4B). Both analyses show a consistent direction
of effect but there was significant heterogeneity (I2: 88% and 79%,
respectively), consistent with the variation in study design and
predictor used.
A further nine studies reporting odds ratios and five studies
reporting Hazard ratios were used to analyze the effect of low
SES on hospital readmission for acute asthma, producing a pooled
OR: 1.25 (95%CI: 1.07-1.47; N = 111062; I2: 84%) (Figure 4C)
and a pooled HR: 1.20 (95%CI: 1.07-1.35; N = 42440; I2: 9%))
(Figure 4D).
Comorbidities
Seven reports analyzed the risk of hospital readmission among children
with other concomitant allergic diseases, including allergic conjuncti-
vitis, allergic rhinitis, or eczema. The pooled OR of six of these studies
showed an increased risk of hospital readmission for asthma for
children with concomitant allergic diseases (OR: 1.90, 95%CI: 1.43-
2.52; N = 32387; I2: 44%) (E-Figure S1).
3.3.2 | Factors related to asthma characteristics
Previous ED or hospital admission
Eight reports included data on the risk of ED or hospital readmission
according to a history of previous hospital or ED admissions, either in
the previous 12-24 months (the most common) or ever in life. The
three reports studying ED re-attendance odds ratios are shown in
Figure 5A. The pooled OR for two of these studies was 2.94 (95%CI:
2.71-3.20; N = 29689; I2: 0%). The results from one of the studies
(Taylor 1999) was not included in themeta-analysis and forest plot as it
pooled together all children who had not had an asthma attack in the
baseline year (whether they had asthma or not).
The tworeports studyinghazard ratios (HR:1.88,95%CI:1.58-2.24;
N = 40367; I2: 78%), showed an increased rate among children with a
history of previous ED or hospital admissions for acute asthma
(Figure 5B). The same occurred with the eight studies reporting
odds ratio (OR: 2.37, 95%CI: 1.78-3.14; N = 76929; I2: 94%) and the
three studies reporting hazard ratios for hospital readmission (HR: 2.54,
FIGURE 3 Forest plots for the associations of ethnicity (black vs other) with emergency department re-attendance and hospital
readmission for acute asthma in children using a random effects model
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95%CI: 1.84-3.52; N = 30193; I2: 47%) (Figures 5C and 5D). One of the
studies (Taylor 1999) was not included in the pooled analysis of the
odds ratio for hospital readmissions, for the same reason as exposed
above. Although there was apparent heterogeneity between studies
in these analyses, the direction of effect was consistent and
individual studies found similar effect sizes so indicative pooled
effect sizes are shown.
Asthma severity and controller treatment
Ten studies assessed the association between asthma severity, control
or controller treatment received with the risk of ED or hospital
readmission (E-Table S4). The type of predictor and definition of
severity varied greatly between studies, precluding a meta-analysis.
The findings related to severity as defined by treatment were
inconsistent.
3.3.3 | Factors related to potential follow-up
Asthma follow-up
Tenpapers examinedaspects of follow-up after the indexEDor hospital
admission (E-Table S5). Three studies explored the effect of the
Children's Asthma Care (CAC) measures set implementation, which
comprises providing reliever medication and systemic corticosteroids
for childrenadmitted tohospital for asthma, anddischarging themwith a
home management plan. They showed no effect on ED re-attendance
FIGURE 4 Forest plots for the associations of socioeconomic status (SES) with emergency department re-attendance and hospital
readmission for acute asthma in children using a random effects model
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after the initial admission for asthma and two of them demonstrated
a reduced risk of hospital re-admission after the implementation of
the CAC measures. One further study showed a decreased risk
of both hospital readmission and ED re-utilization for acute
asthma after Home Management Plan Care implementation (part
of CAC).21
Five studies analyzed the effect of different follow-up visit
characteristics and ED or hospital readmission for asthma with
disparate outcomes. Three reports studied the effect of receiving an
asthma action plan at discharge on the risk of ED or hospital
readmission. Two of them were combined (E-Figure S2) showing no
association.
3.3.4 | Other factors
Exposure to tobacco smoke (ETS)
Five studies included data on ETS, producing a pooled odds ratio of
1.60 (95%CI: 0.94-2.72;N = 1041; I2: 49%) for hospital readmission for
acute asthma for those exposed to tobacco smoke (E-Figure S3). One
other paper22measuringHazard ratio, showed no association between
ETS and hospital readmission rate for asthma (AHR: 0.83, 95%CI: not
published, P-value: not significant).
Other factors included: family history of asthma or allergic
diseases, parental level of education, personal history (previous
immunizations, early life feeding methods), caregiver's situation
(psychological stress, beliefs, knowledge, marital status, or concerns),
asthma triggers, exposure to allergens or pollution and home
characteristics, adherence to asthma treatment, characteristics of
index asthma admission, and home remediation interventions of water
infiltration. The outcome definitions and specific exposures studied
were highly heterogeneous between studies meaning no robust
consensus conclusions could be drawn.
4 | DISCUSSION
4.1 | Summary of main findings
Asthma is a very common reason for emergency attendance. Clinicians
are therefore often faced with decisions on whether to increase
FIGURE 5 Forest plots for the associations of previous ED or hospital admissions for acute asthma with emergency department re-
attendance and hospital readmission for acute asthma in children using a random effects model
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treatment and who to refer for a specialist opinion. This systematic
review and meta-analysis has identified a history of previous ED or
hospital admissions as the major risk factor for emergency care and
hospital readmissions for acute asthma in children. Further, our results
indicate that children of African-American ethnicity (compared to
white or other ethnicity), low socioeconomic status (as measured by
having public insurance or low family income), with concomitant
allergic diseases (allergic rhinitis/rhinoconjunctivitis or eczema)
and being younger than 5 years of age, appear at a greater risk of
subsequent emergency care visits or hospital readmissions for acute
asthma.
4.2 | Strengths
This systematic review answers a relevant question with public health
implications for future asthma management. It has been developed in
accordance with best practice and using an extensive search with no
time or language publication restrictions to ensure the inclusion of
potentially suitable studies. Risk of bias was assessed and presented
for each included study separately. We were also able to undertake a
quantitative analysis of the most relevant predictors, increasing the
relevance of our findings.
4.3 | Limitations
The data collected had a moderate to low strength of evidence, due to
the quality of the included studies and the inconsistent findings in
some of the factors reported.23,24 Most of observational studies
included were retrospective cohorts using hospital or insurance
databases with a large number of patients (more than 10 000
participants in six studies). However, unclear and high risk of bias
were common because of inadequate sampling and reporting of only
significant results in more than 50% of the observational studies. The
RCT's included in the review had some important risk of biases which
precluded increasing the strength of evidence of the review.
Variation in studydesign andoutcomesprecludedmeta-analysis for
some factors. In other instances, meta-analyses demonstrated signifi-
cant variation between studies when compared to error within studies
(high I2). In most of these cases we present pooled effect size to give an
indication of the scale and direction of effect. However, it is not
currently possible to derive precise estimates of effect size based on the
available literature, and well-designed prospective studies are required.
Despite a wide literature search with no language restriction, all
selected papers were published in English and the clear majority were
developed in Anglophone countries, mainly in the US. This likely
reflects the fact that asthma has been an important public health
problem in these countries for a long period2 but limits the
generalizability of the findings to other relevant regions such as Latin
America were asthma has emerged as an important public health
issue.25 Decisions on who should be the focus of treatment are crucial
in such settings where resources are likely to be very limited. Another
important factor is the inclusion of children younger than 2 years old in
several studies, an age at which it is difficult to ascertain an asthma
diagnosis.26 The outcomes used in the studies are also a possible
source of bias, as there is no consensus on when a child should be
admitted to the ED or hospital for acute asthma. However, this is the
current definition used by the ATS for an episode of severe asthma.27
4.4 | Findings in relation to other studies
The use of different study designs and effect measures meant that for
most factors under study there was not a simple way to summarize the
effect of a given risk factor. However, the effect sizes reported were
similar in the most relevant predictors identified, such as low socio-
economic status or history of ED or hospital admission for acute
asthma during the previous year. In particular, we did not find a
substantial difference for any given risk factor between effect sizes in
studies considering OR or HR: That is to say there was no clear
difference in effect size when considering whether an exacerbation
would happen in the follow-up period, and frequency of exacerbations.
This is likely to be because most children did not have multiple
exacerbations during follow-up. There are also statistical challenges of
understanding factors that influence the time to event for a potentially
recurrent event.
Children younger than 5 years old were at a higher risk of ED or
hospital readmission for acute asthma when compared to different
age groups in more than half of the studies that explored age as a
predictor of future risk. Preschool children suffer a larger number of
acute asthma attacks driven mostly by respiratory viruses.28,29 It is
also difficult to diagnose asthma in this age group,26 potentially
leading to inadequate management. Lintzenich et al30 showed that
children 1-6 years old hospitalized for asthma were less likely to
receive ICS baseline treatment and asthma education than older
children.
Lower SES was associated with a higher risk and a higher rate of
ED or hospital readmission.31 Similar associations had been previously
described for other diseases.32 It may reflect poorer long-term
management due to inadequate access to primary and specialist
care, and that caregiversmay be less able to adequatelymanage a long-
term condition thus relying more on ED attendance. Flores et al33
showed that among ethnic minority children with asthma in urban
settings, poorer children were less likely to have an asthma specialist
than wealthier children.
Children of African-American origin living in Anglophone coun-
tries were at higher risk of re-attendance for asthma. Non-white
ethnicity has also been described as a predictor of hospitalization or ED
visits in adults with severe or difficult-to-treat asthma.34 Beck et al35
reported that up to 80% of the readmission disparity between African-
American and white asthmatic children could be explained by other
associated factors, such as access to care or disease management.
However, it is uncertain how applicable these findings are outside an
urban United States setting.
Co-existing allergic diseases (allergic rhinitis/rhinoconjunctivitis
and eczema) were also associated with a greater risk of hospital
readmission for asthma. Previous work has shown that treatment for
allergic rhinitis (nasal corticosteroids and antihistamines) is associated
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with lower rates of unscheduled care use.36 This may indicate that
untreated comorbid allergic diseases are associated with higher risk of
asthma hospital readmissions.
Asthmatic children with a history of a previous ED or hospital
admission for acute asthma had 2-5.8 times more risk of ED
re-attendance and 2.5-3 times more risk of a hospital readmission.
This was therefore the clearest factor related to asthma that was
associated with future risk. Similarly, other studies have identified
several variables related to previous healthcare utilization for acute
asthma that are associated with future risk of severe asthma
attacks.37,38
5 | CONCLUSION
In conclusion, we have identified individual-level and factors related to
asthma severity that are associatedwith a greater risk of future asthma
attacks requiring emergency care or hospital readmission. This
description of the current evidence base and its limitations could
help inform future prospective studies that robustly assess the
magnitude and interaction of such risk factors. In future, being able
to identify children at risk of future asthma attacks requiring
emergency care will guide specific interventions such as educational
sessions, management of comorbidities, and personalized treatment
adjustments. This approach has the potential to reduce the chance of
long-term complications such as loss of lung function, psychological
morbidity, and death.
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